Canonical: https://ownershiptrace.com/13f/companies/699

# Who owns TAKEDA PHARMACEUTICAL CO LTD (TAK)? Elite investor 13F holders

5 tracked elite investors reported holding TAKEDA PHARMACEUTICAL CO LTD as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Tudor Investment, Pzena Investment Management, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive,…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 41165040.00 USD | 2568000.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 32852956.00 USD | 2049467.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1605388.00 USD | 100149.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Pzena Investment Management](https://ownershiptrace.com/13f/investors/64) | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 606253.00 USD | 37820.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1027796/0001027796-26-000049-index.html) |
| [Ancora Advisors / Ancora Holdings](https://ownershiptrace.com/13f/investors/101) | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 22646.00 USD | 1413.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1446114/0001446114-26-000012-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)